Stay updated on JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.

Latest updates to the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page
- Check7 days agoChange DetectedA new version entry (Version 42) was added on 2026-02-12, and a Study Status update was recorded on 2026-02-13. These additions update the visible status information in the study's record history.SummaryDifference0.2%

- Check14 days agoChange DetectedA new site revision (v3.4.2) was added and the temporary government-funding notice (and older revision v3.4.1) was removed. There is no impact on study data, content, or access to the records. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide notice regarding funding-related delays was added, and the release version was updated to v3.4.1, replacing v3.4.0.SummaryDifference0.5%

- Check28 days agoChange DetectedUI/UX updates include a glossary toggle, new color-coding for diffs (green for additions, red for deletions), and a revision label change from v3.3.4 to v3.4.0. These changes do not affect trial data or core content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check35 days agoChange DetectedAdded a new Study Status entry on 2026-01-16, expanding the version history and reflecting the current status of the trial record. A prior version dated 2025-12-24 was removed.SummaryDifference0.3%

- Check57 days agoChange DetectedA new version dated 2025-12-18 adds a 'Study Status' entry and updates the version count to 40. The 2025-12-05 version entry was removed.SummaryDifference0.3%

Stay in the know with updates to JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JNJ-79635322 Study in Relapsed/Refractory Myeloma: Clinical Trial page.